| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
MDR 4Q FY25 Investor Presentation
|
31 Jul 2025 9:25AM |
$0.079 |
$0.022 |
fallen by
72.15%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported strong revenue growth for 4Q FY25 compared to previous periods.
- Continued expansion of the digital health services and patient engagement platform.
- Strengthened market position in Australia and expanded presence internationally.
- Updates provided on recent mergers, acquisitions, and strategic partnerships.
- Increased uptake of digital adherence programs and pharmacy technology solutions.
- Investments made in technology innovation and product development.
- Positive outlook driven by ongoing execution of MedAdvisor’s global growth strategy.
- Focus on scalable and recurring revenue streams through digital solutions.
- Engagement with large healthcare and pharmaceutical partners for new programs.
- Positioned as a leader in medication management and digital patient engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Associate Global Partners Limited (APL) ORDINARY FULLY PAID |
Financials |
$17 |
Quarterly Activity Report and Appendix 4C
|
31 Jul 2025 9:25AM |
$0.115 |
$0.300 |
risen by
160.87%
|
|
APL - Price-sensitive ASX Announcement
Full Release
Key Points
- APL achieved positive net inflows for the quarter, reflecting robust investor support.
- The company successfully launched new funds, contributing to diversification and growth in FUM.
- Distribution partnerships were expanded, increasing the reach and accessibility of APL products.
- Cash flows remained stable, with the company maintaining a disciplined approach to cost management.
- Operational highlights included improved efficiency and continued investment in growth opportunities.
- Strategic priorities remain focused on growing FUM, expanding distribution, and enhancing client outcomes.
- The Appendix 4C provides details on cash receipts, payments, and overall liquidity for the quarter.
- Future outlook emphasizes ongoing innovation, partnership development, and pursuit of new growth avenues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Humm Group Limited (HUM) ORDINARY FULLY PAID |
Financials |
$326 |
Update in relation to non-binding indicative proposal
|
31 Jul 2025 9:25AM |
$0.580 |
$0.645 |
risen by
11.21%
|
|
HUM - Price-sensitive ASX Announcement
Full Release
Key Points
- Humm Group Limited received a non-binding, indicative acquisition proposal from an entity linked to its founder, Andrew Abercrombie.
- The Board has carefully reviewed the proposal with independent financial and legal advice.
- The proposal was rejected as it undervalued HUM and lacked certainty of execution.
- The Board is focused on maximizing shareholder value and is open to considering credible future proposals.
- HUM will keep shareholders updated on any material changes or further developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurora Labs Limited (A3D) ORDINARY FULLY PAID |
Industrials |
$26 |
Retirement of Director
|
31 Jul 2025 9:24AM |
$0.039 |
$0.050 |
risen by
28.21%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$36 |
Investor Webinar
|
31 Jul 2025 9:24AM |
$0.145 |
$0.125 |
fallen by
13.79%
|
|
| Alma Metals Limited (ALM) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$38 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:24AM |
$0.005 |
$0.017 |
risen by
277.78%
|
|
ALM - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated Mineral Resource Estimate for Briggs, Mannersley & Fig Tree Copper Project to 415 million tonnes at 0.25% copper
- Completed eleven diamond drill holes totaling 3,588 metres during the quarter
- Significant copper intersections reported from drilling, with assay results pending for several holes
- Initiated regional exploration activities including geological mapping and soil geochemistry
- Ongoing assessment of additional project opportunities in copper-gold systems
- Operating cash outflows were predominantly for exploration and evaluation activities
- Administrative and corporate costs recognized in the cash flow statement
- End-of-quarter cash balance was $3.7 million
- No significant production or revenue reported during the quarter
- Compliance with ASX Listing Rules and disclosure of related party payments
- Company remains focused on advancing the Briggs Project and evaluating strategic growth opportunities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$100 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:23AM |
$0.310 |
$0.205 |
fallen by
33.87%
|
|
ART - Price-sensitive ASX Announcement
Full Release
Key Points
- Airtasker posted strong growth in GMV and revenue for Q2 FY24 compared to the prior year.
- Marketplace GMV was $67.6 million, up 18.1% year-on-year.
- Operating revenue increased to $14.4 million, reflecting a 15.1% rise from the previous year.
- The company achieved positive net operating cash flow of $1.6 million for the quarter.
- UK and US markets saw significant revenue growth, driven by targeted investments.
- Product engagement improved, with a focus on enhancing the user experience.
- Cash balance at 31 December 2023 stood at $23.4 million.
- Management remains focused on international market expansion and product innovation.
- Airtasker is positioned for scalable growth through strategic investments and operational efficiency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omega Oil & Gas Limited (OMA) ORDINARY FULLY PAID |
Energy |
$436 |
Quarterly Activities Report and Appendix 5B
|
31 Jul 2025 9:23AM |
$0.300 |
$0.860 |
risen by
186.67%
|
|
OMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Canyon-2 well successfully drilled and flowed gas from the Kianga Formation.
- Preparations progressed for drilling the Canyon-1 well in the Surat Basin.
- Focus on commercialisation options and ongoing discussions with customers and infrastructure providers.
- Exploration expenditure and financial activities detailed; $7.7 million cash at quarter end.
- No production or revenue was recorded during the quarter.
- Omega holds a 100% interest in ATP 2037 and ATP 2038 in the Surat Basin.
- Appendix 5B reports operating and investing cash outflows for the period.
- No significant environmental or regulatory issues reported during the quarter.
- Board and management remain focused on progressing the company's exploration and development strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boab Metals Limited (BML) ORDINARY FULLY PAID |
Materials |
$271 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:23AM |
$0.180 |
$0.470 |
risen by
161.11%
|
|
BML - Price-sensitive ASX Announcement
Full Release
Key Points
- Advanced off-take and financing discussions for the Sorby Hills Lead-Silver-Zinc Project.
- Continued engagement with potential project partners and stakeholders.
- Maintained strong cash position with prudent cost management.
- Exploration activities and studies continued to progress project development.
- No significant environmental or safety incidents reported during the quarter.
- Lodged Appendix 5B Cash Flow Report for the quarter ending 31 March 2024.
- Focused on achieving Final Investment Decision (FID) for Sorby Hills in 2024.
- Corporate activities included ongoing investor engagement and regulatory compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Critical Minerals Group Limited (CMG) ORDINARY FULLY PAID |
Materials |
$10 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:22AM |
$0.170 |
$0.100 |
fallen by
41.18%
|
|
CMG - Price-sensitive ASX Announcement
Full Release
Key Points
- CMG completed a Pre-Feasibility Study (PFS) for the Lindfield Vanadium Project, indicating positive technical and economic results.
- Ongoing metallurgical test work and environmental baseline studies are being conducted to support project development.
- Stakeholder engagement with government and landholders has progressed during the period.
- CMG's closing cash balance was $2.90 million as of 30 June 2023.
- The company is focused on advancing the Lindfield project towards future development stages.
- Sound financial management continues, with cash flow reporting and expenditure control in place.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
MDR 4Q FY25 Quarterly Activity Report and 4C
|
31 Jul 2025 9:22AM |
$0.079 |
$0.022 |
fallen by
72.15%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- MedAdvisor reported strong revenue growth in 4Q FY25.
- Significant progress was made in global digital health programs.
- The company achieved key commercial wins, particularly in the US market.
- Cost management remained a key focus, enabling operational efficiency.
- Expansion of patient engagement and adherence solutions was noted.
- The report details positive cash flow and improved financial position.
- The outlook for the next quarters remains positive, with continued investment in technology and innovation.
- Board and management changes were highlighted as part of ongoing business optimisation.
- The document includes Appendix 4C, providing detailed cash flow information.
- MedAdvisor reaffirmed its commitment to digital healthcare transformation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Augustus Minerals Limited (AUG) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:22AM |
$0.042 |
$0.041 |
fallen by
2.38%
|
|
AUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Augustus Minerals Limited completed an extensive drilling campaign at the Ti-Tree Project.
- Initial assay results indicate promising lithium, copper, and REE mineralisation.
- Geochemical and geophysical surveys identified new high-priority targets for follow-up exploration.
- The company maintains a strong cash position to fund ongoing exploration efforts.
- Cash outflows were primarily directed towards exploration and evaluation activities.
- Preparations are underway for additional drilling and exploration in the upcoming quarter.
- No mining production or development activities were undertaken during the quarter.
- The company is focused on maximising shareholder value through systematic exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conrad Asia Energy Ltd (CRD) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$96 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:22AM |
$0.780 |
$0.495 |
fallen by
36.54%
|
|
CRD - Price-sensitive ASX Announcement
Full Release
Key Points
- Conrad Asia Energy Ltd provided a quarterly update for the period ending March 31, 2024.
- Significant progress was made on the Mako Gas Project in Indonesia, including POD approval and regulatory engagement.
- New gas sales agreements and heads of agreement were signed to support project commercialization.
- Exploration and appraisal activities continued, with technical work advancing on key licenses.
- Financial summary includes cash inflows from financing and cash outflows related to exploration and operational activities.
- Company maintains a strong liquidity position and manages capital prudently.
- Ongoing discussions with government authorities and partners to advance upstream and commercial objectives.
- The report provides a detailed breakdown of quarterly cash flow as per Appendix 5B requirements.
- Outlook emphasizes continued efforts to secure project approvals, finalize commercial agreements, and progress developments in the next quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iltani Resources Limited (ILT) ORDINARY FULLY PAID |
Materials |
$42 |
Maiden Orient West JORC Mineral Resource Estimate
|
31 Jul 2025 9:21AM |
$0.200 |
$0.540 |
risen by
170%
|
|
ILT - Price-sensitive ASX Announcement
Full Release
Key Points
- Iltani Resources Limited released a Maiden JORC Mineral Resource Estimate for the Orient West Project.
- The project is located in northern Queensland and contains significant silver, lead, and zinc mineralization.
- Resource estimation follows the guidelines set by JORC 2012.
- The report details geological setting, exploration history, sampling, drilling, and data validation procedures.
- Potential exists for resource expansion with further exploration and drilling.
- All technical data, relevant tables, and statements are included to support estimation transparency.
- The report emphasizes compliance and best practices in resource reporting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pointerra Limited (3DP) ORDINARY FULLY PAID |
Information Technology |
$25 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:21AM |
$0.057 |
$0.030 |
fallen by
47.37%
|
|
3DP - Price-sensitive ASX Announcement
Full Release
Key Points
- Pointerra Limited released its Quarterly Activities and Appendix 4C Cash Flow Report for Q3 FY2024.
- The company’s 3D data management platform (3DP) continues to gain traction, especially in the US energy utilities market.
- New contract wins and renewals with existing customers have contributed to ongoing revenue growth.
- Operational highlights include platform enhancements and expansion into new verticals and geographies.
- Cash receipts for the quarter were reported alongside a summary of operating expenditure and available cash.
- Management remains focused on cost control and efficient cash management.
- Compliance with ASX Listing Rules and related party transactions are disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Reinstatement to Quotation
|
31 Jul 2025 9:21AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Winchester Energy Limited (WEL) to be reinstated to quotation on ASX.
- Reinstatement follows a period of suspension due to non-compliance with listing rules.
- Company has completed a capital raising as required by the ASX.
- WEL has addressed corporate governance and financial reporting requirements.
- Announcement includes timeline for reinstatement of securities.
- Disclosure obligations remain in place for ongoing transparency.
- Reinstatement was announced on 7 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:21AM |
$0.034 |
$0.028 |
fallen by
17.65%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- EVE Health Group Limited provided its Quarterly Activities Report and Appendix 4C for the quarter ended 31 March 2024.
- The company continued its focus on the development and commercialization of diagnostic and health technologies.
- Updates were given on product development, regulatory approvals, and partnership initiatives.
- Key operational highlights included progress in clinical studies, product launches, and market expansion strategies.
- Financially, the report included a summary of cash receipts, payments for research and development, product manufacturing, and operating costs.
- The cash flow statement detailed the company’s cash position at the end of the period and highlighted expenditure areas.
- EVE Health Group outlined its strategy for capitalizing on market opportunities and sustaining growth.
- The report confirmed compliance with ASX Listing Rule 4.7C, including details on payments to related parties.
- Future plans include continued investment in proprietary technology, expansion into new markets, and ongoing regulatory engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$228 |
June 2025 Quarterly Business Review & Appendix 4C
|
31 Jul 2025 9:20AM |
$0.450 |
$0.700 |
risen by
55.56%
|
|
DAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Reviewed key operational achievements and challenges for the quarter
- Outlined financial performance including receipts, expenses, and net cash position
- Reported on new customer acquisitions and commercial partnership progress
- Detailed ongoing development in AI-driven product offerings
- Summarized updates in sales pipeline growth and revenue generation
- Discussed investment in R&D and platform enhancements
- Explained management of cash flows and funding requirements
- Responded to ASX Appendix 4C compliance items and regulatory questions
- Highlighted strategic outlook and plans for the upcoming quarters
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Board Appointments
|
31 Jul 2025 9:20AM |
$0.001 |
$0.002 |
risen by
100%
|
|
WEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement of board changes at Winchester Energy Limited (WEL) on 20 November 2023
- Appointment of Tony Gu as Non-Executive Chairman
- Appointment of Peter Mills and David McAuley as Non-Executive Directors
- Resignation of John Kopcheff and Neville Bassett from the board
- Board changes are immediate and part of company’s efforts to strengthen governance
- New directors bring industry experience and expertise to support company growth
- Board composition adjustments align with company’s strategic objectives
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$22 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2025 9:20AM |
$0.150 |
$0.220 |
risen by
46.67%
|
|
JNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities report and Appendix 4C cash flow report for the period ending 31 March 2024
- Continued development and commercialisation of electric truck technology
- Completed key technical upgrades and battery swap enhancements
- First on-road trials of electric prime movers conducted
- Established a new collaboration with a global logistics company
- Advanced discussions for pilot programs with major industry players
- Reported net operating cash outflows due to research, development, and administrative expenses
- Maintained sufficient cash reserves for upcoming planned activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2025 9:20AM |
$0.014 |
$0.010 |
fallen by
28.57%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- CR3 advanced lithium and rare earth element exploration projects in Australia (WA, NT) and Canada.
- Successful grant and acquisition of multiple exploration tenements and license applications.
- Resource definition and drilling programs commenced or planned at highly prospective sites.
- Partnerships and community engagement activities were undertaken with First Nations in Canada.
- CR3 participated in key mining industry events and government delegations.
- Company maintained a strong cash balance, ending the quarter with approximately $5.6 million.
- Exploration and evaluation expenditure for the quarter totaled $1.24 million.
- No mining production or sales occurred during the quarter.
- Detailed Appendix 5B Cash Flow statement included, outlining receipts, payments, and financing activities.
- Compliance statements and a comprehensive list of tenements held, acquired, or applied for were disclosed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$85 |
June Quarterly Activities & Cash Flow Report
|
31 Jul 2025 9:19AM |
$0.019 |
$0.375 |
risen by
1,873.68%
|
|
IXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Ionic Rare Earths Limited (IonicRE) released its June 2023 Quarterly Activities and Cash Flow Report.
- The Makuutu Rare Earths Project in Uganda remains the company’s primary focus, with continued progress on the Demonstration Plant and ongoing work to support the Feasibility Study and Mining Licence Application.
- The company reported positive developments around resource definition drilling, metallurgical testwork, and completion of the Demonstration Plant, which will provide mixed rare earth carbonate product for offtake discussions.
- Offtake and strategic partnership discussions progressed during the quarter, with multiple parties interested in securing future supply of rare earths from Makuutu.
- Ionic Technologies’ Belfast demonstration plant produced recycled rare earth oxides from end-of-life magnets, advancing its position in rare earth recycling.
- IonicRE continued to engage with multiple potential strategic partners and offtake parties, focusing on supply chain resilience and ESG credentials.
- The company maintained a solid cash position at the end of the quarter, with financials detailed in the accompanying Appendix 5B cash flow report.
- No significant mining production or exploration was conducted outside the main Makuutu Project area.
- Future work will include completion of the Demonstration Plant activities, further engagement with potential partners, and advancing the Makuutu Project towards development.
- There were no payments to related parties during the quarter except for Board and management fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$99 |
Update - Notification of buy-back - CAM
|
31 Jul 2025 9:19AM |
$0.705 |
$0.700 |
fallen by
0.71%
|
|
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$34 |
MX1 - Quarterly Activities Report & Appendix 4C
|
31 Jul 2025 9:19AM |
$0.086 |
$0.047 |
fallen by
45.35%
|
|
MX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported quarterly cash receipts of $1.6 million, with closing cash balance of $7.7 million as at 31 March 2024.
- Revenue was primarily driven by Mobile DR sales in both Australian and US markets.
- Continued progress in Checkpoints, including delivery and installation of new technology for US Transportation Security Administration (TSA) trials.
- Argus project advanced with further engineering milestones and ongoing engagement with potential customers in defence and security sectors.
- CT business unit made strides towards commercialization, with technology development and initial market engagement.
- Ongoing cost control measures were implemented to manage cash burn and extend operational runway.
- Research and development remains a significant focus, with investments in new technology platforms.
- No significant changes in related party transactions during the quarter.
- Directors are confident of meeting medium-term operational and financial objectives.
- Funding and capital management remain priorities, with the company actively exploring opportunities to strengthen financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$42 |
Quarterly Activities Report and Appendix 4C - 30 Jun 25
|
31 Jul 2025 9:19AM |
$0.027 |
$0.056 |
risen by
107.41%
|
|
XRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Report and Appendix 4C released for the quarter ending 30 June 2025.
- Growth in recurring revenue from digital reality training solutions.
- Successful development and release of new training modules and platform features.
- Increased engagement with government, law enforcement, and enterprise clients.
- Expansion of market reach through new partnerships and international projects.
- Strong cash balance and disciplined expenditure management.
- Continued investment in technology and innovation.
- Focus on scaling operations and delivering value to shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
